55 results
8-K
EX-99.1
BTAX
Biostax Corp.
14 Jan 15
Departure of Directors or Certain Officers
12:00am
and marketing of novel, patented therapies to combat chronic, life-threatening diseases through the activation and modulation of the body’s immune system … .
We are a biotechnology company working to combat chronic, life-threatening diseases through the activation and modulation of the body's immune system
8-K
EX-99.1
BTAX
Biostax Corp.
20 Jan 15
Immune Therapeutics, Inc. Announces Appointment of New Director and Acceptance of Election by Director
12:00am
, distribution and marketing of novel, patented therapies to combat chronic, life-threatening diseases through the activation and modulation of the body’s … are a biotechnology company working to combat chronic, life-threatening diseases through the activation and modulation of the body's immune system using our patented
8-K
EX-99.1
BTAX
Biostax Corp.
19 Feb 20
Immune Therapeutics, Inc. Appoints New Independent Director
4:31pm
immunotherapy to treat life-threatening or chronic diseases announced the appointment of Mr. Michael L. Sander to its Board of Directors who will succeed … on its mission to improve the lives of patients who are suffering from chronic illness.”
Mr. Sander is currently Managing Director of Sortis Capital
8-K
EX-99.1
BTAX
Biostax Corp.
26 Jul 13
TNI BioTech Receives Meeting Minutes from FDA Type C Meeting on Naltrexone HCL for the treatment of Crohn’s Disease
12:00am
, allowing the clinical trials to begin first quarter of 2014."
About TNI BioTech, Inc.
TNI BioTech, Inc., is a biotech company working to combat chronic … technologies are designed to harness the power of the immune system to improve the treatment of cancer, infections such as HIV/AIDS, chronic
8-K
EX-99.1
BTAX
Biostax Corp.
21 Apr 16
Immune Therapeutics signs Binding Letter of Intent to Acquire Chinese CAR-T Technology and Clinical Data
12:00am
Immune Therapeutics, Inc.:
Immune Therapeutics, Inc. [F/K/A TNI Biotech, Inc.] is a biotechnology company working to combat chronic, life … technologies are designed to harness the power of the immune system to improve the treatment of cancer, infections such as HIV/AIDS, chronic inflammatory
8-K
EX-20.1
ngyhz1378w6ci3
7 Jun 13
Other Events
12:00am
10-Q
kxs278uh8mgj637
15 May 13
Quarterly report
12:00am
8-K
EX-99.1
zgxu2z xu
9 Sep 14
Submission of Matters to a Vote of Security Holders
12:00am
8-K
EX-99.1
hwh6e30jl6pn6mszkrk4
14 Sep 23
Biostax Corp Announces the Passing of Esteemed Director, Henry Louis Salomonsky
9:00am
8-K
EX-99.1
6j04b0tutajw1rltkj82
5 May 20
Departure of Directors or Certain Officers
5:19pm
10-12G
jxqfqlj fp00
22 Apr 13
Registration of securities
12:00am
8-K
EX-99.1
09a 01jco7srq5jxo982
3 Jun 22
Departure of Directors or Certain Officers
4:57pm
10-12G/A
n0d0yykwwc o1zo
7 Jun 13
Registration of securities (amended)
12:00am
8-K
EX-99.1
at6498
11 Jun 18
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
99hwxq44r
2 Nov 23
Biostax Announces the Appointment of Ms. Mary Clay Caperton to its Board of Directors
9:00am
8-K
EX-99.1
roko0u
24 Oct 23
Amendments to Articles of Incorporation or Bylaws
9:00am
CORRESP
afn svdkwqbxl
7 Jun 13
Correspondence with SEC
12:00am
10-12G/A
m0e7j1pgm5g2cp
18 Jul 13
Registration of securities (amended)
12:00am